Stage IIIA Uterine Corpus Cancer [clinicaltrials_resource:489f810eaa06790313e4d25188cc9ff8]
Intraperitoneal Paclitaxel, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Stage III-IV Endometrial Cancer [clinicaltrials:NCT00575952]Temsirolimus With or Without Megestrol Acetate and Tamoxifen Citrate in Treating Patients With Advanced, Persistent, or Recurrent Endometrial Cancer [clinicaltrials:NCT00729586]Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer [clinicaltrials:NCT00942357]Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer [clinicaltrials:NCT00977574]Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer [clinicaltrials:NCT01010126]Dasatinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer [clinicaltrials:NCT01440998]clinicaltrials:NCT01522820clinicaltrials:NCT02065687Paclitaxel and Intraperitoneal Carboplatin Followed by Radiation Therapy in Treating Patients With Stage IIIC-IV Uterine Cancer [clinicaltrials:NCT02112552]Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing Surgery [clinicaltrials:NCT02315469]clinicaltrials:NCT02501954
condition [clinicaltrials_vocabulary:condition]
Stage IIIA Uterine Corpus Cancer [clinicaltrials_resource:489f810eaa06790313e4d25188cc9ff8]
Bio2RDF identifier
489f810eaa06790313e4d25188cc9ff8
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:489f810eaa06790313e4d25188cc9ff8
identifier
clinicaltrials_resource:489f810eaa06790313e4d25188cc9ff8
title
Stage IIIA Uterine Corpus Cancer
@en
label
Stage IIIA Uterine Corpus Canc ...... f810eaa06790313e4d25188cc9ff8]
@en